新しいマクロ分子構造は,プロミエロサイト-レチノ酸受容体オンコプロテインの標的である
J A Dyck1, G G Maul, W H Miller
1Biomedical Sciences Graduate Progam University of California, San Diego, La Jolla 92037.
Cell
|January 28, 1994
まとめ
急性プロミエロサイト性白血病は,PML-RARアルファ融合遺伝子がPML腫瘍性ドメイン (POD) を破壊することを含む. レチノ酸治療はPODを回復させ,その破壊が白血病を引き起こすことを示唆しています.
科学分野:
- 血液学 ヘマトロジ
- 分子生物学は分子生物学である.
- 腫瘍学 腫瘍学
背景:
- 急性プロミエロサイト性白血病 (APL) は,t(15;17) 転位によって特徴付けられています.
- この転位により,PML-RARアルファ融合遺伝子が形成されます.
- PMLタンパク質は,PML腫瘍性ドメイン (POD) と呼ばれる新しい核構造の構成要素です.
研究 の 目的:
- APL.の病原性におけるPML腫瘍性ドメイン (POD) の役割を調査する.
- PML-RARアルファオンコタンパク質がPODの構造と機能にどのように影響するかを理解する.
- APLにおける治療目標としてのPODの潜在能力を探求する.
主な方法:
- 免疫ヒストケミストリーは,APL細胞のPMLとPODを視覚化するために使用されました.
- APL細胞におけるPODに対するレチノ酸 (RA) 治療の効果を調べました.
- PML-RARアルファがPODアセンブリに影響するメカニズムが調査されました.
主要な成果:
- PMLの腫瘍性ドメイン (POD) は,複数の核タンパク質を含む新しいマクロ分子器官である.
- APL細胞では,PML-RARアルファオンコタンパク質が通常のPOD構造を破壊し,マイクロ粒子のパターンが形成されます.
- レチノ酸治療は,PMLの再編成を誘発し,APL細胞の正常に見えるPODを回復しました.
結論:
- PML-RARアルファオンコプロテインは,ドミニントネガティブで作用し,PODアセンブリを阻害する.
- PML-RARアルファによるPODの破壊は,骨髄膜の成熟を阻害し,白血病発生に貢献することが提案されています.
- PMLの腫瘍性ドメインは,急性プロミエロサイト性白血病の新たな治療標的となる可能性がある.
関連する概念動画
Receptor-mediated Endocytosis
Overview
Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor-mediated Endocytosis
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Structure of Porins
Mitochondria, chloroplasts, and gram-negative bacteria have transmembrane, beta-barrel proteins called porins to mediate the free diffusion of ions and metabolites across the membrane. Mitochondrial porin precursors contain conserved amino acid sequences called beta signals at their C-terminal. Beta signals have a motif of PoXGXXHyXHy (Po-Polar, X-Any amino acid, G-Glycine, Hy-LargeHydrophobic), which are crucial for precursor recognition to initiate precursor assembly. Beta-barrel precursors...
Receptor-Mediated Endocytosis
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...


